Xuemeng Ji
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xuemeng Ji has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Shuo Wang
Tianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300350, China
13 shared publications Juan Xue
12 shared publications- Ping Lu
Tianjin Key Laboratory of Ophthalmology and Visual Science, Nankai University Affiliated Eye Hospital ,Tianjin Eye Institute, Tianjin Eye Hospital, Tianjin, China
9 shared publications - Huan Lv
Tianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300071, China
8 shared publications Aiying Shi
7 shared publications- Jin Wang
Tianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300350, China
6 shared publications
Latest Publications
- Open Access
A 12-Week Multi-Ingredient Joint Health Supplement Alleviates Activity-Related Knee Discomfort and Improves Pain-Limited Load Tolerance in Endurance-Trained Adults: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial
Background: Activity-related knee discomfort is common in endurance-trained adults. Multi-ingredient supplements targeting complementary biological pathways may support knee comfort and load tolerance in this population, but controlled evidence is limited. Methods: In this randomized, double-blind, placebo- and active-comparator-controlled pilot trial, 60 endurance-trained adults (20 per group) with activity-related knee discomfort received for 12 weeks either a multi-ingredient formula (undenatured type II collagen, curcumin phytosome, and enzymatically hydrolyzed bone powder; Group A), glucosamine hydrochloride plus chondroitin sulfate (Group B), or placebo (Group C). Assessments of functional and patient-reported outcomes were conducted at baseline, week 6, week 12, and 24 h after a post-intervention half-marathon challenge. Outcome measures covered functional pain tolerance, patient-reported pain symptoms, exploratory biomarkers of cartilage turnover, inflammation, and oxidative stress. Results: Group-by-time interactions were significant for SLSD repetitions to pain levels 2 and 5 and for VAS (all p < 0.0001). At week 12, Group A exceeded placebo for the SLSD repetitions to pain level 5 (mean difference 30.5 repetitions; 95% CI 8.7 to 52.3; p = 0.0201), for SLSD repetitions to pain level 2 (21.4; 8.8 to 34.1; p = 0.0037), and for VAS (−1.6; −2.6 to −0.7; p = 0.0030), whereas Group B differed from placebo for SLSD pain level 2 and VAS but not for the SLSD pain level 5. No direct comparison between Groups A and B was statistically significant (all adjusted p > 0.05). After the half-marathon, only Groups B and C showed significant within-group declines in ROM relative to baseline (p = 0.0262 and p = 0.0147), whereas Group A did not (p > 0.99), although between-group ROM contrasts were not significant. Biomarker changes were exploratory, and no between-group biomarker difference reached significance. Conclusions: In this pilot trial, 12 weeks of multi-ingredient supplementation improved pain-limited knee load tolerance and self-reported knee pain relative to placebo in endurance-trained adults. These results require confirmation in a larger trial.
Open AccessA 12-Week Multi-Ingredient Joint Health Supplement Alleviates Activity-Related Knee Discomfort and Improves Pain-Limited Load Tolerance in Endurance-Trained Adults: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial
Background: Activity-related knee discomfort is common in endurance-trained adults. Multi-ingredient supplements targeting complementary biological pathways may support knee comfort and load tolerance in this population, but controlled evidence is limited. Methods: In this randomized, double-blind, placebo- and active-comparator-controlled pilot trial, 60 endurance-trained adults (20 per group) with activity-related knee discomfort received for 12 weeks either a multi-ingredient formula (undenatured type II collagen, curcumin phytosome, and enzymatically hydrolyzed bone powder; Group A), glucosamine hydrochloride plus chondroitin sulfate (Group B), or placebo (Group C). Assessments of functional and patient-reported outcomes were conducted at baseline, week 6, week 12, and 24 h after a post-intervention half-marathon challenge. Outcome measures covered functional pain tolerance, patient-reported pain symptoms, exploratory biomarkers of cartilage turnover, inflammation, and oxidative stress. Results: Group-by-time interactions were significant for SLSD repetitions to pain levels 2 and 5 and for VAS (all p < 0.0001). At week 12, Group A exceeded placebo for the SLSD repetitions to pain level 5 (mean difference 30.5 repetitions; 95% CI 8.7 to 52.3; p = 0.0201), for SLSD repetitions to pain level 2 (21.4; 8.8 to 34.1; p = 0.0037), and for VAS (−1.6; −2.6 to −0.7; p = 0.0030), whereas Group B differed from placebo for SLSD pain level 2 and VAS but not for the SLSD pain level 5. No direct comparison between Groups A and B was statistically significant (all adjusted p > 0.05). After the half-marathon, only Groups B and C showed significant within-group declines in ROM relative to baseline (p = 0.0262 and p = 0.0147), whereas Group A did not (p > 0.99), although between-group ROM contrasts were not significant. Biomarker changes were exploratory, and no between-group biomarker difference reached significance. Conclusions: In this pilot trial, 12 weeks of multi-ingredient supplementation improved pain-limited knee load tolerance and self-reported knee pain relative to placebo in endurance-trained adults. These results require confirmation in a larger trial.
- Open Access
Synergistic Effects of Nutritional Formula on Joint Inflammation Through Modulation of Bone Metabolism in Rats
Background: Joint inflammation is significantly connected with progressive joint deterioration, potentially increasing the incidence of persistent major clinical challenges and global disability. Nutrient-based preventive strategies have been explored to investigate the interventive efficacy of the proposed prescribed formula for joint inflammation. However, the synergistic ameliorative effects of the nutritional formula should be evaluated to investigate its impact on joint inflammation. Methods: A prescribed formula including turmeric (T), N-acetylglucosamine (G), enzymatically hydrolyzed bone powder (E), and undenatured type II collagen (U) was comprehensively evaluated for its synergistic effects on joint inflammation and the underlying mechanisms. A rat model established using the Hulth method was used to evaluate the interventive effects in vivo. Moreover, in vitro analysis using the murine chondrogenic cell line ATDC5 was performed to validate the intervention and its mechanism of action. Results: The prescribed formula was shown to synergistically reduce levels of inflammation-related cytokines, reduce oxidative stress, and enhance bone metabolism to promote joint regeneration. Micro-Computed Tomography (Micro-CT) analysis revealed restoration of joint architecture and ameliorated physiological status upon formula intervention. In vitro analysis further validated the synergistic alleviation of inflammation and oxidation, as well as reductions in MMP13 and CTX-1 levels, which implies that modulating bone metabolism alleviates the deterioration and inflammation of joint architecture. Conclusions: The synergistic formula in this study achieves synchronous modulation of several core pathological pathways, yielding synergistic modulation of joint inflammation. Nutrient-based interventions or preventive strategies show promising effects against joint inflammation and progressive mechanistic deterioration.
Open AccessSynergistic Effects of Nutritional Formula on Joint Inflammation Through Modulation of Bone Metabolism in Rats
Background: Joint inflammation is significantly connected with progressive joint deterioration, potentially increasing the incidence of persistent major clinical challenges and global disability. Nutrient-based preventive strategies have been explored to investigate the interventive efficacy of the proposed prescribed formula for joint inflammation. However, the synergistic ameliorative effects of the nutritional formula should be evaluated to investigate its impact on joint inflammation. Methods: A prescribed formula including turmeric (T), N-acetylglucosamine (G), enzymatically hydrolyzed bone powder (E), and undenatured type II collagen (U) was comprehensively evaluated for its synergistic effects on joint inflammation and the underlying mechanisms. A rat model established using the Hulth method was used to evaluate the interventive effects in vivo. Moreover, in vitro analysis using the murine chondrogenic cell line ATDC5 was performed to validate the intervention and its mechanism of action. Results: The prescribed formula was shown to synergistically reduce levels of inflammation-related cytokines, reduce oxidative stress, and enhance bone metabolism to promote joint regeneration. Micro-Computed Tomography (Micro-CT) analysis revealed restoration of joint architecture and ameliorated physiological status upon formula intervention. In vitro analysis further validated the synergistic alleviation of inflammation and oxidation, as well as reductions in MMP13 and CTX-1 levels, which implies that modulating bone metabolism alleviates the deterioration and inflammation of joint architecture. Conclusions: The synergistic formula in this study achieves synchronous modulation of several core pathological pathways, yielding synergistic modulation of joint inflammation. Nutrient-based interventions or preventive strategies show promising effects against joint inflammation and progressive mechanistic deterioration.
- Open Access
Dandelion Leaf Aqueous Extract Relieves Hyperuricemia and Its Complications via Modulating Uric Acid Metabolism, Renal Inflammation, and Gut Microbes
Dandelion is an edible and medicinal plant that has beneficial effects in various complex disorders. In this study, we investigated the regulatory effects of dandelion leaf aqueous extract (DAE) on mice with hyperuricemia (HUA) and explored its underlying mechanisms. DAE exhibited a high total phenolic content (363.31 ± 0.61 mg GAC/g) and contained 20 identified polyphenolic compounds. The administration of DAE significantly reduced serum uric acid levels and exerted protective effects on both liver and kidney function in mice with HUA. Mechanistically, DAE inhibited the NLRP3/Caspase-1 and TLR4/MyD88/NF-κB signaling pathways, leading to the downregulated mRNA expression of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α), thereby alleviating renal inflammation. Additionally, DAE modulated the gut microbiota composition and increased SCFA-producing bacteria, along with increases in fecal SCFA contents. These findings suggest that DAE effectively mitigates HUA and its associated renal complications by regulating uric acid metabolism, suppressing renal inflammation, and restoring gut microbial homeostasis. Thus, DAE holds promise as a natural adjuvant therapy for HUA and related kidney inflammation.
Open AccessDandelion Leaf Aqueous Extract Relieves Hyperuricemia and Its Complications via Modulating Uric Acid Metabolism, Renal Inflammation, and Gut Microbes
Dandelion is an edible and medicinal plant that has beneficial effects in various complex disorders. In this study, we investigated the regulatory effects of dandelion leaf aqueous extract (DAE) on mice with hyperuricemia (HUA) and explored its underlying mechanisms. DAE exhibited a high total phenolic content (363.31 ± 0.61 mg GAC/g) and contained 20 identified polyphenolic compounds. The administration of DAE significantly reduced serum uric acid levels and exerted protective effects on both liver and kidney function in mice with HUA. Mechanistically, DAE inhibited the NLRP3/Caspase-1 and TLR4/MyD88/NF-κB signaling pathways, leading to the downregulated mRNA expression of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α), thereby alleviating renal inflammation. Additionally, DAE modulated the gut microbiota composition and increased SCFA-producing bacteria, along with increases in fecal SCFA contents. These findings suggest that DAE effectively mitigates HUA and its associated renal complications by regulating uric acid metabolism, suppressing renal inflammation, and restoring gut microbial homeostasis. Thus, DAE holds promise as a natural adjuvant therapy for HUA and related kidney inflammation.
- 23 September 2025
- Published by Elsevier in Food Bioscience
- Vol. 73
The GlrKR two-component system modulates virulence, environmental stress responses, and p-coumaric acid sensitivity in Cronobacter sakazakii
- 23 September 2025
- Published by Elsevier in Food Bioscience
- Vol. 73
The GlrKR two-component system modulates virulence, environmental stress responses, and p-coumaric acid sensitivity in Cronobacter sakazakii
- 22 September 2025
- Published by Elsevier in Research in Microbiology
- Vol. 176  (8) , 104340
Decoding the functionality of pESA3 in Cronobacter sakazakii: A balancing act between survival and pathogenicity
- 22 September 2025
- Published by Elsevier in Research in Microbiology
- Vol. 176  (8) , 104340
Decoding the functionality of pESA3 in Cronobacter sakazakii: A balancing act between survival and pathogenicity
- 12 August 2025
- Published by Elsevier in Research in Microbiology
- Vol. 176  (7) , 104321
Metabolic adaptation via glycolysis and iron acquisition drives Klebsiella pneumoniae–induced intraocular inflammation and visual impairment
- 12 August 2025
- Published by Elsevier in Research in Microbiology
- Vol. 176  (7) , 104321
Metabolic adaptation via glycolysis and iron acquisition drives Klebsiella pneumoniae–induced intraocular inflammation and visual impairment
- 11 August 2025
- Published by Elsevier in International Journal of Food Microbiology
- Vol. 442, 111385
Sep, a YieP homolog, orchestrates membrane remodeling and multi-stress resistance in Salmonella enterica isolates from food
- 11 August 2025
- Published by Elsevier in International Journal of Food Microbiology
- Vol. 442, 111385
Sep, a YieP homolog, orchestrates membrane remodeling and multi-stress resistance in Salmonella enterica isolates from food
- 5 August 2025
- Published by Elsevier in Food Research International
- Vol. 221  (Pt 1) , 117229
Fatty acid metabolism governed by FadR is essential for Cronobacter sakazakii survival in dry food matrices and neonatal infection
- 5 August 2025
- Published by Elsevier in Food Research International
- Vol. 221  (Pt 1) , 117229
Fatty acid metabolism governed by FadR is essential for Cronobacter sakazakii survival in dry food matrices and neonatal infection
- 7 July 2025
- Published by Elsevier in Food Microbiology
- Vol. 132, 104860
Opposing regulation of Gig2 by RecA and GlrK controls redox-linked desiccation tolerance in Cronobacter sakazakii
- 7 July 2025
- Published by Elsevier in Food Microbiology
- Vol. 132, 104860
Opposing regulation of Gig2 by RecA and GlrK controls redox-linked desiccation tolerance in Cronobacter sakazakii
- Open Access
- 4 June 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15  (1) , 1-13
Radiosensitizing effects of Withaferin A in gastric cancer cells via autophagy Inhibition and mitochondrial disruption
Gastric cancer is highly lethal due to late-stage diagnosis and resistance to standard treatments like radiotherapy. Enhancing radiosensitivity in gastric cancer cells could improve treatment outcomes. Withaferin A (WA), a bioactive compound from Withania somnifera, has anticancer effects and can modulate cellular processes like autophagy and mitochondrial function. This study investigates WA’s role in enhancing radiosensitivity by targeting apoptosis, autophagy, and mitochondrial function in SGC-7901 gastric cancer cells. In both in vitro and in vivo models, combined WA and radiation (IR) treatment significantly inhibited tumor growth, as evidenced by reduced tumor size in xenografts. Mechanistically, this combination promoted apoptosis, with increased levels of cleaved caspase-3 and PARP, indicating enhanced cell death. WA altered autophagic dynamics by activating autophagy and blocking autophagic flux, shown by LC3II accumulation and SQSTM1/p62 buildup. Moreover, the combined treatment disrupted mitochondrial function, leading to decreased ATP production, reduced respiratory capacity, and increased proton leakage, which contributed to cellular stress. These findings suggest that WA may serve as a radiosensitizer to enhance radiotherapy efficacy in gastric cancer, highlighting its therapeutic potential and advocating for further exploration of phytocompounds in cancer treatment.
- 4 June 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15  (1) , 1-13
Open AccessRadiosensitizing effects of Withaferin A in gastric cancer cells via autophagy Inhibition and mitochondrial disruption
Gastric cancer is highly lethal due to late-stage diagnosis and resistance to standard treatments like radiotherapy. Enhancing radiosensitivity in gastric cancer cells could improve treatment outcomes. Withaferin A (WA), a bioactive compound from Withania somnifera, has anticancer effects and can modulate cellular processes like autophagy and mitochondrial function. This study investigates WA’s role in enhancing radiosensitivity by targeting apoptosis, autophagy, and mitochondrial function in SGC-7901 gastric cancer cells. In both in vitro and in vivo models, combined WA and radiation (IR) treatment significantly inhibited tumor growth, as evidenced by reduced tumor size in xenografts. Mechanistically, this combination promoted apoptosis, with increased levels of cleaved caspase-3 and PARP, indicating enhanced cell death. WA altered autophagic dynamics by activating autophagy and blocking autophagic flux, shown by LC3II accumulation and SQSTM1/p62 buildup. Moreover, the combined treatment disrupted mitochondrial function, leading to decreased ATP production, reduced respiratory capacity, and increased proton leakage, which contributed to cellular stress. These findings suggest that WA may serve as a radiosensitizer to enhance radiotherapy efficacy in gastric cancer, highlighting its therapeutic potential and advocating for further exploration of phytocompounds in cancer treatment.